JavaScript is disabled for your browser. Some features of this site may not work without it.
We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
| dc.contributor.author | Visser, Adele
|
|
| dc.contributor.author | Hoosen, Anwar Ahmed
|
|
| dc.date.accessioned | 2011-08-03T06:29:51Z | |
| dc.date.available | 2011-08-03T06:29:51Z | |
| dc.date.issued | 2011-05 | |
| dc.description.abstract | The WHO advocates introduction of routine HPV vaccination as part of a national EPI programme provided HPV prevention is considered a health priority, and the programme is logistically feasible and financially sustainable. High vaccine costs are often cited as barriers to national public health usage. However, a recent study in Cape Town showed a cost benefit for routine HPV vaccination use. Cervical cancer screening programmes should continue, as genotypes not included in the vaccines may still cause malignant transformation. | en_US |
| dc.description.uri | http://www.cmej.org.za/index.php/cmej | en_US |
| dc.identifier.citation | Viser, A & Hoosen, A 2011, 'More about... medical virology : Human papillomavirus (HPV)', CME : Continuing Medical Education, vol. 29, no. 5, pp. 214. | en_US |
| dc.identifier.issn | 1016-6742 (print) | |
| dc.identifier.issn | 2078-5143 (online) | |
| dc.identifier.uri | http://hdl.handle.net/2263/16984 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | Health and Medical Publishing Group | en_US |
| dc.subject | Human papillomavirus (HPV) vaccines | en_US |
| dc.title | More about... medical virology : Human papillomavirus (HPV) | en_US |
| dc.type | Article | en_US |
